Bright Minds Biosciences (DRUG) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Bright Minds Biosciences (DRUG) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Bright Minds Biosciences

· DRUG

Dashboard

Financials

Ratios

Valuation

Statistics

490.638 M

+0.16%

General

Market Cap: $490.64M
Enterprise Value: $380.37M
Shares Outstanding: 9,810,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -7.96%
ROE: -12.56%
ROIC: -12.92%
Current Ratio: 121.97
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.20
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -9.57

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $27.97M
Operating Income: -$28M
Net Profit: -$17.38M

Balance Sheet

Cash and Equivalents: $216.38M
Working Capital: $216.44M
Total Assets: $218.26M
Net Debt: -$216.33M
Total Liabilities: $1.79M
Total Equity: $216.47M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$17.55M
Cash Flow from Investing: —
Cash Flow from Financing: $194.5M
Free Cash Flow: -$17.55M
Capital Expenditures: $2.81